Cynaropicrin: a comprehensive research review and therapeutic potential as an anti- hepatitis C virus agent

The different pharmacologic properties of plants-containing cynaropicrin, especially artichokes, have been known for many centuries. More recently, cynaropicrin exhibited a potential activity against all genotypes of hepatitis C virus (HCV). Cynaropicrin has also shown a wide range of other pharmaco...

Full description

Bibliographic Details
Main Authors: Mahmoud Fahmi Elsebai, Andrei Mocan, Atanas G. Atanasov
Format: Article
Language:English
Published: Frontiers Media S.A. 2016-12-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fphar.2016.00472/full
_version_ 1819241263227994112
author Mahmoud Fahmi Elsebai
Andrei Mocan
Atanas G. Atanasov
Atanas G. Atanasov
author_facet Mahmoud Fahmi Elsebai
Andrei Mocan
Atanas G. Atanasov
Atanas G. Atanasov
author_sort Mahmoud Fahmi Elsebai
collection DOAJ
description The different pharmacologic properties of plants-containing cynaropicrin, especially artichokes, have been known for many centuries. More recently, cynaropicrin exhibited a potential activity against all genotypes of hepatitis C virus (HCV). Cynaropicrin has also shown a wide range of other pharmacologic properties such as anti-hyperlipidemic, anti-trypanosomal, anti-malarial, antifeedant, antispasmodic, anti-photoaging, and anti-tumor action, as well as activation of bitter sensory receptors, and anti-inflammatory properties (e.g., associated with the suppression of the key pro-inflammatory NF-κB pathway). These pharmacological effects are very supportive factors to its outstanding activity against HCV. Structurally, cynaropicrin might be considered as a potential drug candidate, since it has no violations for the rule of five and its water-solubility could allow formulation as therapeutic injections. Moreover, cynaropicrin is a small molecule that can be easily synthesized and as the major constituent of the edible plant artichoke, which has a history of safe dietary use. In summary, cynaropicrin is a promising bioactive natural product that, with minor hit-to-lead optimization, might be developed as a drug for HCV.
first_indexed 2024-12-23T14:21:08Z
format Article
id doaj.art-4369e22f09af47deabe430406184257b
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-12-23T14:21:08Z
publishDate 2016-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-4369e22f09af47deabe430406184257b2022-12-21T17:43:48ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122016-12-01710.3389/fphar.2016.00472231724Cynaropicrin: a comprehensive research review and therapeutic potential as an anti- hepatitis C virus agentMahmoud Fahmi Elsebai0Andrei Mocan1Atanas G. Atanasov2Atanas G. Atanasov3Department of Pharmacognosy, Faculty of Pharmacy, Mansoura UniversityDepartment of Pharmaceutical Botany, Iuliu Hațieganu University of Medicine and PharmacyUniversity of ViennaInstitute of Genetics and Animal Breeding of the Polish Academy of SciencesThe different pharmacologic properties of plants-containing cynaropicrin, especially artichokes, have been known for many centuries. More recently, cynaropicrin exhibited a potential activity against all genotypes of hepatitis C virus (HCV). Cynaropicrin has also shown a wide range of other pharmacologic properties such as anti-hyperlipidemic, anti-trypanosomal, anti-malarial, antifeedant, antispasmodic, anti-photoaging, and anti-tumor action, as well as activation of bitter sensory receptors, and anti-inflammatory properties (e.g., associated with the suppression of the key pro-inflammatory NF-κB pathway). These pharmacological effects are very supportive factors to its outstanding activity against HCV. Structurally, cynaropicrin might be considered as a potential drug candidate, since it has no violations for the rule of five and its water-solubility could allow formulation as therapeutic injections. Moreover, cynaropicrin is a small molecule that can be easily synthesized and as the major constituent of the edible plant artichoke, which has a history of safe dietary use. In summary, cynaropicrin is a promising bioactive natural product that, with minor hit-to-lead optimization, might be developed as a drug for HCV.http://journal.frontiersin.org/Journal/10.3389/fphar.2016.00472/fullAntibacterialHepatitis C virusanti-inflammatoryantitumorAnti-hyperlipidemicAnti-parasite
spellingShingle Mahmoud Fahmi Elsebai
Andrei Mocan
Atanas G. Atanasov
Atanas G. Atanasov
Cynaropicrin: a comprehensive research review and therapeutic potential as an anti- hepatitis C virus agent
Frontiers in Pharmacology
Antibacterial
Hepatitis C virus
anti-inflammatory
antitumor
Anti-hyperlipidemic
Anti-parasite
title Cynaropicrin: a comprehensive research review and therapeutic potential as an anti- hepatitis C virus agent
title_full Cynaropicrin: a comprehensive research review and therapeutic potential as an anti- hepatitis C virus agent
title_fullStr Cynaropicrin: a comprehensive research review and therapeutic potential as an anti- hepatitis C virus agent
title_full_unstemmed Cynaropicrin: a comprehensive research review and therapeutic potential as an anti- hepatitis C virus agent
title_short Cynaropicrin: a comprehensive research review and therapeutic potential as an anti- hepatitis C virus agent
title_sort cynaropicrin a comprehensive research review and therapeutic potential as an anti hepatitis c virus agent
topic Antibacterial
Hepatitis C virus
anti-inflammatory
antitumor
Anti-hyperlipidemic
Anti-parasite
url http://journal.frontiersin.org/Journal/10.3389/fphar.2016.00472/full
work_keys_str_mv AT mahmoudfahmielsebai cynaropicrinacomprehensiveresearchreviewandtherapeuticpotentialasanantihepatitiscvirusagent
AT andreimocan cynaropicrinacomprehensiveresearchreviewandtherapeuticpotentialasanantihepatitiscvirusagent
AT atanasgatanasov cynaropicrinacomprehensiveresearchreviewandtherapeuticpotentialasanantihepatitiscvirusagent
AT atanasgatanasov cynaropicrinacomprehensiveresearchreviewandtherapeuticpotentialasanantihepatitiscvirusagent